These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 29872469)

  • 1. Osteoporosis in Human Immunodeficiency Virus Patients - An Emerging Clinical Concern.
    Maffezzoni F; Porcelli T; Karamouzis I; Quiros-Roldan E; Castelli F; Mazziotti G; Giustina A
    Eur Endocrinol; 2014 Feb; 10(1):79-83. PubMed ID: 29872469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone disease in the setting of HIV infection: update and review of the literature.
    Castronuovo D; Cacopardo B; Pinzone MR; Di Rosa M; Martellotta F; Schioppa O; Moreno S; Nunnari G
    Eur Rev Med Pharmacol Sci; 2013 Sep; 17(18):2413-9. PubMed ID: 24089217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The impact of highly active antiretroviral therapy on bone mineral density in human immunodeficiency virus infected patients].
    Guo FP; Yu XB; Luo L; Han Y; Qiu ZF; Zuo LY; Li YL; Yu W; Li TS
    Zhonghua Nei Ke Za Zhi; 2010 Aug; 49(8):649-52. PubMed ID: 20979781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Bone mineral loss in patients with human immunodeficiency virus infection].
    Olmos JM; González-Macías J
    Enferm Infecc Microbiol Clin; 2008 Apr; 26(4):212-9. PubMed ID: 18381041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced bone mineral density in human immunodeficiency virus-infected individuals: a meta-analysis of its prevalence and risk factors.
    Goh SSL; Lai PSM; Tan ATB; Ponnampalavanar S
    Osteoporos Int; 2018 Mar; 29(3):595-613. PubMed ID: 29159533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenesis of osteopenia/osteoporosis induced by highly active anti-retroviral therapy for AIDS.
    Pan G; Yang Z; Ballinger SW; McDonald JM
    Ann N Y Acad Sci; 2006 Apr; 1068():297-308. PubMed ID: 16831930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The physical and psychological effects of HIV infection and its treatment on perinatally HIV-infected children.
    Vreeman RC; Scanlon ML; McHenry MS; Nyandiko WM
    J Int AIDS Soc; 2015; 18(Suppl 6):20258. PubMed ID: 26639114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bilateral sequential femoral neck stress fractures in young adult with HIV infection on antiretroviral therapy: A case report.
    Chaganty SS; James D
    World J Orthop; 2019 Jun; 10(6):247-254. PubMed ID: 31259148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fragility fractures and bone mineral density in HIV positive women: a case-control population-based study.
    Prior J; Burdge D; Maan E; Milner R; Hankins C; Klein M; Walmsley S
    Osteoporos Int; 2007 Oct; 18(10):1345-53. PubMed ID: 17665239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV infection, bone metabolism, and fractures.
    Güerri-Fernández R; Villar-García J; Díez-Pérez A; Prieto-Alhambra D
    Arq Bras Endocrinol Metabol; 2014 Jul; 58(5):478-83. PubMed ID: 25166038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential predictive factors of osteoporosis in HIV-positive subjects.
    Fausto A; Bongiovanni M; Cicconi P; Menicagli L; Ligabò EV; Melzi S; Bini T; Sardanelli F; Cornalba G; Monforte Ad
    Bone; 2006 Jun; 38(6):893-7. PubMed ID: 16377270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone diseases associated with human immunodeficiency virus infection: pathogenesis, risk factors and clinical management.
    Bongiovanni M; Tincati C
    Curr Mol Med; 2006 Jun; 6(4):395-400. PubMed ID: 16900662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endocrine complications of human immunodeficiency virus infection: hypogonadism, bone disease and tenofovir-related toxicity.
    Cotter AG; Powderly WG
    Best Pract Res Clin Endocrinol Metab; 2011 Jun; 25(3):501-15. PubMed ID: 21663843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C virus coinfection as a risk factor for osteoporosis and fracture.
    Bedimo R; Maalouf NM; Lo Re V
    Curr Opin HIV AIDS; 2016 May; 11(3):285-93. PubMed ID: 26890206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of screening practices for low bone mass and prevalence of osteoporosis and fractures in people living with human immunodeficiency virus attending a sexual health clinic.
    Davidson N; Sowden D
    Intern Med J; 2019 Sep; 49(9):1119-1124. PubMed ID: 31081166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of highly active antiretroviral therapy on liver function in human immunodeficiency virus-infected pediatric patients with or without hepatitis virus co-infection.
    Wu L; Jin C; Bai S; Davies H; Rao H; Liang Y; Wu N
    J Res Med Sci; 2015 Feb; 20(2):127-32. PubMed ID: 25983763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human immunodeficiency virus in total hip arthroplasty.
    Pietrzak JRT; Maharaj Z; Mokete L; Sikhauli N
    EFORT Open Rev; 2020 Mar; 5(3):164-171. PubMed ID: 32296550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of highly active anti-retroviral therapy and hepatitis C virus co-infection on serum levels of pro-inflammatory and immunoregulatory cytokines in human immunodeficiency virus-1-infected individuals.
    Tornero C; Alberola J; Tamarit A; Navarro D
    Clin Microbiol Infect; 2006 Jun; 12(6):555-60. PubMed ID: 16700705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone disease in HIV infection.
    Saccomanno MF; Ammassari A
    Clin Cases Miner Bone Metab; 2011 Jan; 8(1):33-6. PubMed ID: 22461801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.